Larkberget AB OMXSTO:LARK:
LÄRKBERGET INVESTS 50 MSEK IN NAXS AB
Larkberget Invests SEK 50 Mln In Naxs AB
Earlier from Larkberget Ab
- LARK: Strategic shift to investment focus completed; strong cash, first investments imminent
- LARK: CombiGene halts R&D, posts SEK 44.9m loss, and shifts focus to investments or dividends
- LARK: Strategic Partner A/S proposes a new board led by Luca Di Stefano for CombiGene
- LARK: Gene therapy focus sharpened, COZY prioritized, and cost cuts extend liquidity to 2026